Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr
|Shares Outstanding||EPS||0.73||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-5.61%||Sales Growth - Q/Q||-6.31%||P/E||38.01|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-1.54%||ROE||-3.89%||ROI||-1.94%|
|Current Ratio||1.29||Quick Ratio||0.91||Long Term Debt/Equity||5.3||Debt Ratio||0.38|
|Gross Margin||70.26%||Operating Margin||-6.43%||Net Profit Margin||-3.43%||Dividend Payout Ratio|
|Cash From Financing Activities||-94 M||Cash From Investing Activities||-51 M||Cash From Operating Activities||-197 M||Gross Profit||1.3 B|
|Net Profit||102 M||Operating Profit||219 M||Total Assets||17.12 B||Total Current Assets||3.77 B|
|Total Current Liabilities||1.94 B||Total Debt||5.11 B||Total Liabilities||10.54 B||Total Revenue||1.84 B|
|High 52 week||40.52||Low 52 week||26.11||Last close||39.99||Last change||-1.31%|
|RSI||72.1||Average true range||0.77||Beta||0.89||Volume||4.25 M|
|Simple moving average 20 days||2.63%||Simple moving average 50 days||8.75%||Simple moving average 200 days||13.73%|
|Performance Week||-0.05%||Performance Month||7.41%||Performance Quart||17.44%||Performance Half||16.01%|
|Performance Year||51.02%||Performance Year-to-date||13.16%||Volatility daily||1.04%||Volatility weekly||2.33%|
|Volatility monthly||4.77%||Volatility yearly||16.53%||Relative Volume||246.39%||Average Volume||7.5 M|
|New High||New Low|
2019-03-21 11:45:13 | Why An FDA Probe Is Rocking The Boat For These Medical Device Makers
2019-03-21 09:53:01 | Abbott's ABT HeartMate 3 Pump Study Shows Favorable Results
2019-03-21 09:52:01 | Edwards Lifesciences Presents Positive Partner 3 Trial Data
2019-03-20 11:05:03 | Medtronic MDT Releases Encouraging Evalut TAVR Result
2019-03-19 12:21:04 | Boston Scientific BSX Rides on Acquisitions, Innovation
2019-03-19 12:19:04 | Boston Scientific's EP Arm Gets a Lift From Study Success
2019-03-18 17:17:00 | Dow Adds 65 Points as Markets Look Ahead to the Fed Meeting
2019-03-18 15:04:44 | BofA Lowers Boston Scientific Revenue Estimates On FDA Warning, But Keeps Buy Rating
2019-03-14 09:43:01 | Boston Scientific's WATCHMAN FLX LAAC Device Gets CE Mark
2019-03-12 10:24:43 | See what the IHS Markit Score report has to say about Boston Scientific Corp.
2019-03-11 13:41:42 | Mass. firms riding bull market to nearly $1 trillion in gains
2019-03-11 07:00:00 | Boston Scientific Announces Scheduled Data at EHRA 2019 Congress
2019-03-08 09:30:02 | Boston Scientific BSX Up 1.9% Since Last Earnings Report: Can It Continue?
2019-03-04 15:13:31 | Healthcare ETF Keeps Hitting New Highs
2019-03-01 10:00:30 | Two under-the-radar health-care stocks are trading at record highs
2019-02-28 07:30:00 | Report: Exploring Fundamental Drivers Behind Boston Scientific, United Insurance, MPLX LP, Arthur J. Gallagher, Axis Capital, and Bemis — New Horizons, Emerging Trends, and Upcoming Developments
2019-02-21 20:29:52 | Nevro Corp NVRO Q4 2018 Earnings Conference Call Transcript
2019-02-21 18:45:00 | Boston Scientific Prices $4.3 Billion of Senior Notes
2019-02-21 10:30:02 | Here Are the Key Growth Catalysts for Boston Scientific in 2019
2019-02-21 09:00:31 | Will Boston Scientific or Abbott Report Higher Margins?
2019-02-21 08:00:00 | The Future Is Now; Med Tech That’s Changing Lives
2019-02-21 07:31:31 | Boston Scientific or Abbott: Who Is Controlling Expenses Better?
2019-02-20 15:02:12 | Boston Scientific spent $800M to settle mesh implant lawsuits last year
2019-02-20 11:05:19 | Boston Scientific or Abbott: A Look at Expected EPS Growth
2019-02-20 09:35:17 | Boston Scientific or Abbott: Who Will Report More Revenue Growth?
2019-02-20 08:04:25 | What Analysts Recommend for Boston Scientific and Abbott
2019-02-19 18:48:10 | Boston Scientific Corp BSX Files 10-K for the Fiscal Year Ended on December 31, 2018
2019-02-14 09:07:35 | BSX is Breaking Out for the First Time Since September 2018
2019-02-13 08:25:01 | Boston Scientific Benefits From New Buyouts & Product Launch
2019-02-12 15:18:08 | Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp
2019-02-09 08:04:26 | Is Boston Scientific Corporation NYSE:BSX Investing Effectively In Its Business?
2019-02-08 08:00:34 | See what the IHS Markit Score report has to say about Boston Scientific Corp.
2019-02-07 16:43:09 | Bright Near-Term Outlook for Medical Instruments Industry
2019-02-07 09:30:02 | Company News For Feb 7, 2019
2019-02-07 07:59:08 | 3 Big Stock Charts for Thursday: FirstEnergy, Boston Scientific and Mondelez
2019-02-06 19:48:43 | Boston Scientific BSX Q4 2018 Earnings Conference Call Transcript
2019-02-06 17:11:18 | Edited Transcript of BSX earnings conference call or presentation 6-Feb-19 1:00pm GMT
2019-02-06 16:46:50 | Snap and Capri Holdings rise while Electronic Arts tumbles
2019-02-06 16:35:54 | This Highly Rated Medtech Is Staring Down A Buy Point After Earnings Beat
2019-02-06 16:04:09 | Boston Scientific BSX Beats on Q4 Earnings, Margins Dip
2019-02-06 16:02:01 | Stocks end lower amid mixed corporate earnings
2019-02-06 14:43:23 | Boston Scientific Rises on 4th-Quarter Results
2019-02-06 13:36:06 | Final Trades: eBay, Twitter, L Brands, Boston Scientific, & McKesson
2019-02-06 10:12:06 | Stocks Turn Lower, But These Top Stocks Break Out On Earnings